Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:03 PM
Ignite Modification Date:
2025-12-24 @ 4:03 PM
NCT ID:
NCT06789666
Eligibility Criteria:
Inclusion Criteria:
In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
* Written informed assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information.
* Subject is willing and able to comply with study procedures based on the judgment of the investigator.
* Age 18-25 years at the time of consent.
* Childhood cancer survivor, defined as having cancer between birth 17 years of age and who has completed cancer treatment.
* Reliable internet connection and access to a computer, smartphone, or iPad to support application and virtual study visits.
* Answers "yes" to the question "Do you experience mood issues (yes or no)?".
Exclusion Criteria:
* All subjects meeting any of the exclusion criteria at baseline will be excluded from study participation.
* Patients who lack interest in art. Screening question: Are you open to making art on a scale from 1-5 (1 being not at all, and 5 being very much; must score 3 or higher).
* Subjects who lack basic technology skills (Screening question: On a scale of 1-5 (1 being uncomfortable, and 5 being very comfortable), how would you rate your comfort using websites. Must score 3 or higher).
* Subjects unable to provide consent.
* Other conditions or factors which in the opinion of the Pl would not make the patient a good candidate for the study.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
25 Years
Study:
NCT06789666
Study Brief:
Protocol Section:
NCT06789666